The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Interleukin-6 induces cellular insulin resistance in hepatocytes.
Open accessAbstract
Interleukin (IL)-6 is one of several proinflammatory cytokines that have been associated with insulin resistance and type 2 diabetes. A two- to threefold elevation of circulating IL-6 has been observed in these conditions. Nonetheless, little evidence supports a direct role for IL-6 in mediating insulin resistance. Here, we present data that IL-6 can inhibit insulin receptor (IR) signal transduction and insulin action in both primary mouse hepatocytes and the human hepatocarcinoma cell line, HepG2. This inhibition depends on duration of IL-6 exposure, with a maximum effect at 1-1.5 h of pretreatment with IL-6 in both HepG2 cells and primary hepatocytes. The IL-6 effect is characterized by a decreased tyrosine phosphorylation of IR substrate (IRS)-1 and decreased association of the p85 subunit of phosphatidylinositol 3-kinase with IRS-1 in response to physiologic insulin levels. In addition, insulin-dependent activation of Akt, important in mediating insulin's downstream metabolic actions, is markedly inhibited by IL-6 treatment. Finally, a 1.5-h preincubation of primary hepatocytes with IL-6 inhibits insulin-induced glycogen synthesis by 75%. These data suggest that IL-6 plays a direct role in insulin resistance at the cellular level in both primary hepatocytes and HepG2 cell lines and may contribute to insulin resistance and type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“consistent with previous studies that indicate IL-6 promotes hepatic insulin resistance through IL-6/STAT3induced inhibition of insulin receptor signaling 18,45,46”
From Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis (2024) · cites this paper as [45]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“genes reported to be involved in hepatic insulin resistance, including Il6 45-48 , Spp1 49,50 and Igfbp1 51”
From Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis (2024) · cites this paper as [45]
In the citing paper
“In cultured hepatocytes (25)(26)(27)(28), preadipocytes, and mature adipocytes (29), IL-6 directly impairs insulin action.”
From Signaling Specificity of Interleukin-6 Action on Glucose and Lipid Metabolism in Skeletal Muscle (2006) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234
A family of cytokine-inducible inhibitors of signalling
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997) · Nature · doi:10.1038/43206 · Cited by 2,066
Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1
Mohamed‐Ali, V., Goodrick, S., Rawesh, A., Katz, D. R., Miles, J. M., Yudkin, J. S., Klein, S., & Coppack, S. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4450 · Cited by 2,032
Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
Kern, P. A., Ranganathan, S., Li, C., Wood, L., & Ranganathan, G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e745 · Cited by 1,883
Pickup, J. C., Mattock, M. B., Chusney, G. D., & Burt, D. J. (1997) · Diabetologia · doi:10.1007/s001250050822 · Cited by 1,246
Cited by
Sorted by citations
Items 801–879 of 879
Metabolic and Nutritional Complications of Acute Kidney Injury
Siew, E. D., & Himmelfarb, J. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0987-2.00047-9
Does white blood cell count predict diabetes incidence in the general Chinese population over time?
Liu, Q., Xu, Y., Liu, K., He, S., Shi, R., & Chen, X. (2016) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-016-0521-6
“Several hormone receptors are expressed on the surface of WBCs and play a role in their production and maturation [5].”
BackgroundThe Role of the Liver Sinusoidal Endothelial Cells in the Pathophysiology of Insulin Resistance
Mohamad, M. (2016) · The Sydney eScholarship Repository (The University of Sydney)
Avaliação da vitamina D na doença hepática gordurosa não alcoólica
de Paula, F. V. L. (2017) · doi:10.11606/d.17.2017.tde-30032017-094325
The Pharmacology of Moringa stenopetala —Effects on Diabetes and Associated Diseases
Habtemariam, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-102286-3.00009-9
Immune cell phenotype and function : impact of type 2 diabetes, obesity, and exercise
Barry, J. (2018) · cIRcle (University of British Columbia) · doi:10.14288/1.0362080
“Mechanistically, IL6 may also impair hepatic insulin signaling [123, 124], which”
BackgroundThe Immediate and Extended Effect of Diet and Exercise on Metabolic Flexibility
Allerton, T. D. (2017) · Louisiana State University · doi:10.31390/gradschool_dissertations.4493
The Role of Physical Activity and Exercise in Acute Metabolic Perturbations to the Liver
Peppler, W. T. (2018) · The Atrium (University of Guelph)
Varghese, D. A., Christy, A. J., Pratheeba, B., Saraswathy, P., & Ravi, D. S. (2019) · International Journal of Innovative Research in Medical Science · doi:10.23958/ijirms/vol04-i09/742
“IL-6 is one of the very important cytokines associated with insulin resistance.([29]) IL-6 induces insulin resistance by decreased tyrosine phosphorylation of IR substrate (IRS)-1 and decreased association of the p85 subunit of phosphatidylinositol 3-kinase with IRS-1 in response to physiologic insulin levels.”
BackgroundNogueira, J. E. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2020.tde-04102019-162256
Identifying Potential biomarkers of insulin sensitivity and insulin resistance in obese patients
Al‐Sulaiti, H. (2020) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.122707627 · Cited by 1
Okenwa, C., Uzoma, I. C., Onyemelukwe, A. O., Dozie-Nwakile, O. C., Emuebie, H., Edeh, V. C., & Ufelle, S. (2020) · Annual Research & Review in Biology · doi:10.9734/arrb/2020/v35i630231
“It has been found that immune responses controlled by cytokines can determine disease prognosis [5,37].”
BackgroundBecerra-Núñez, E., García-Muñoz, A., Quiróz-Pérez, M. A., & Ibarra-González, F. (2020) · Odontología Vital · doi:10.59334/rov.v1i32.375
Assessment of NF-κB-SN50 Effect on Adipose TNF-α and AGT Secretion and Expression
Dahman, L. S. B., Aldaghri, N., Alfadda, A. A., & Sallam, R. M. (2020) · doi:10.3390/iecbm2020-08822
The Investigation of Mechanisms Underlying Iron Overload Induced Adiponectin Resistance
Prioriello, M. (2017) · YorkSpace (York University)
The impact of interleukin-6 on the metabolic response to endotoxin in vivo
Tweedell, A. D. (2005)
ИНТЕРЛЕЙКИН-6 И ДИАБЕТИЧЕСКАЯ НЕФРОПАТИЯ: ПАТОГЕНЕТИЧЕСКИЕ СВЯЗИ, МИШЕНИ ДЛЯ НЕФРОПРОТЕКЦИИ
Pchelin, I. Y., Байрашева, В. К., Шишкин, А. Н., Vasilkova, V., & Худякова, Н. В. (2017) · Juvenis scientia
Physical activity and cardiovascular disease risk in women with polycystic ovary syndrome
Woodward, A. (2021) · Sheffield Hallam University · doi:10.7190/shu-thesis-00398
Gynostemma Pentaphyllum Ameliorates Lipid Metabolic Abnormalities in Diabetic Kidney DiseasePreprint
Wang, P., Jiao, S., Sun, L., Sun, H., Wang, C., Sun, H., & Zhang, Z. (2021) · Research Square · doi:10.21203/rs.3.rs-1149570/v1
Lacerda, M. G. (2016) · RIUnB Institutional Repository (University of Brasília) · doi:10.26512/2016.12.t.23043
Current literature in diabetes
(2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.347
Kim, J., Kim, Y. M., Park, J. S., Baik, S. J., Chun, J., Youn, Y. H., & Park, H. (2022) · Research Square · doi:10.21203/rs.3.rs-1232675/v1
Błaszczyk, M., Gajewska, M., Dymowska, M., Majewska, A., Domoradzki, T., Prostek, A., Pingwara, R., Hulanicka, M., & Grzelkowska‐Kowalczyk, K. (2022) · Histochemistry and Cell Biology · doi:10.1007/s00418-022-02091-3
Gynostemma Pentaphyllum Ameliorates Lipid Metabolic Abnormalities in Diabetic Kidney DiseasePreprint
Wang, P., Jiao, S., Sun, L., Sun, H., Wang, C., Sun, H., & Zhang, Z. (2022) · Research Square · doi:10.21203/rs.3.rs-1149570/v2
Resistencia a insulina e função da celula 'beta'
Marin, D. M. (2007) · doi:10.47749/t/unicamp.2007.428281
(2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01208c.2006
Metabolic and Nutritional Complications of Acute Kidney Injury
Siew, E. D., & Liu, K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-52978-5.00046-x
Yang, T., Zhao, B., Guan, X., & Pei, D. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-057966
Scheithauer, T. P. M. (2023) · doi:10.5463/thesis.82
Blanco, E., León, J. S. T., Ayala, J. A. G., Peña, V. C., Strauch, R. G. P., Dulcey, L., Artavia, M. P. C., Martínez, J. C., Mayorca, J. C., & Cala, M. A. (2023) · Revista Salud y Desarrollo · doi:10.55717/ydtt3123
Metabolic syndrome and COVID-19: An unholy alliance
Somasundaram, N. P., & Dissanayake, H. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00036-0
Potent inflammatory biomarkers in insulin resistance
Verma, S., Abbas, M., Talwar, A., Anand, S., Nayyar, A., Fatima, F., & Zahera, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13195-0.00012-0
Причини розвитку запалення в тканинах печінки та серця під впливом нейтральних жирів (тригліцеридів)
Кazymyrko, V. К., Silantieva, Т. S., Dubkova, А. G., & Kutovyi, V. V. (2023) · Likarska sprava · doi:10.31640/ls-2023-4-02
Nirmala, S., & Saraswthy, M. (2025) · Journal of advanced health research & clinical medicine. · doi:10.4103/jhcr.jhcr_3_25
Lipoprotein profiles across a spectrum of insulin signaling
Hwang, M., Shamburek, R. D., Sampson, M. L., Abel, B. S., Lightbourne, M., & Brown, R. J. (2025) · Journal of clinical lipidology · doi:10.1016/j.jacl.2025.06.003
Kurata, H., Tsuruta, H., Shigetomi, S., Harun-Or-Roshid, M., & Maeda, K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177688
“In contrast, since IL-13 is a canonical T-helper 2 (Th-2) cytokine, IL-13-inducing peptides drive Th-2-mediated immune responses, contributing to allergic inflammation, parasitic infections, mucus production, and differentiation of naive human B cells toward IgG4-and IgE-producing cells [6,7].”
Bastawros, H. F. (2007) · doi:10.31274/rtd-180813-16004
“Studies performed in vitro have shown that IL-6 inhibits insulin signaling and insulin action in isolated mice hepatocytes and in hepatoma cell lines via a decrease in tyrosine phosphorylation of insulin receptor 1 (IRS1) and protein kinase activation (Senn et al., 2002).”
BackgroundFerrer, B. (2013) · TDX (Tesis Doctorals en Xarxa)
Miao, S., Mu, T., Li, R., Li, Y., Zhao, W., Li, J., Dong, X., & Zou, X. (2024) · Figshare · doi:10.6084/m9.figshare.26673975
Gohari, S., Ismail‐Beigi, F., Mahjani, M., Ghobadi, S., Jafari, A., Ahangar, H., & Gohari, S. (2023) · Figshare · doi:10.6084/m9.figshare.24630303
Correlation of Epicardial Fat Thickness With the Severity of Coronary Artery Disease
Nagoni, K. B., Nandal, R., Mathew, M., Agrawal, B. K., & Bhutani, V. (2025) · Cureus · doi:10.7759/cureus.99005
“It was also found that IL-6 promotes insulin resistance, stimulates gluconeogenesis, and hepatic secretion of triglycerides [12].”
Associations Between First-Trimester Cytokines and Gestational Diabetes
Meng, Y., Thornburg, L. L., Groth, S. W., Barrett, E. S., Miller, R. K., & O’Connor, T. G. (2026) · Diabetology · doi:10.3390/diabetology7020022
Zinc suppresses Stat3-driven IL-6 production in primary mouse adipocytes
Chung, H., Eom, J., Damen, M. S. M. A., Stankiewicz, T. E., Sawada, K., Alarcon, P. C., Ulanowicz, C. J., Wayland, J. L., Deepe, G. S., & Divanovic, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1714168
“…tissue in fl ammation is a known driver of metabolic complications, and that IL-6 speci fi cally has been implicated in hepatocyte insulin resistance (6), atherosclerotic plaque growth (7), and the differentiation (8) and sustenance (9) of the pathogenic Th17 cells, the primary culprits in MASH…”
Immune-targeted therapies: Management of diabetes and fostering healthy aging
Nainu, F., Ophinni, Y., Mamada, S. S., & Latada, N. P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44665-8.00024-9
刘, 平. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1631172
Inflammation intestinale et diabète de type 2 : effet du Resveratrol
Dao, T. M. A. (2011) · theses.fr (ABES) · doi:10.70675/ba3c8576z889ez4199zb7d6z98de312b9efb
THE IMPACT OF THE GUT MICROBIOTA ON THE PATHOGENESIS AND MANAGEMENT OF INSULIN RESISTANCE
Lazarchuk, I., Sydor, M., Plizga, W., Lepa, Z., Kalemba, P., Lipska, P. O., & Majda, A. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.1(49).2026.4962
Implication des neurones exprimant NUCB2/nesfatine-1 dans la régulation de l'homéostasie énergétique
Bonnet, M. S. (2013) · theses.fr (ABES) · doi:10.70675/82840557z70b7z4214zbe5azca1e4f81d53a
“L’IL-6 provoque également une résistance à l’insuline mais à l’inverse de l’IL-1β, elle n’agit pas sur l’expression des transporteurs GLUT-4 mais sur les récepteurs à l’insuline eux- mêmes en affectant leur activité (Kim et al., 2004; Senn et al., 2002).”
Patrier, L. (2014) · theses.fr (ABES) · doi:10.70675/856fba23zd92az4508z88b4z4a6cd1d739dd
Impact de la protéine SHP2 associé au syndrome de Noonan sur le métabolisme glucidique
Paccoud, R. (2018) · theses.fr (ABES) · doi:10.70675/f9b9b046zdf4bz404fz9689z8deb20f6e5ac
“Cependant, les études sur le muscle laissent perplexe quant au rôle de IL‐6, une cytokine pro‐inflammatoire reconnue pour promouvoir la résistance à l’insuline dans le foie (Senn et al., 2002).”
BackgroundMoughaizel, M. (2020) · theses.fr (ABES) · doi:10.70675/d21b4f34z8e9az4348za233z7629490bce9e
Hu, C., Wu, L., Zhang, Z., Liu, Y., Yang, H., Zhou, J., Wu, Y., & Wang, Q. (2026) · iScience · doi:10.1016/j.isci.2026.115675 · Cited by 1
“30 To the best of our knowledge, this study addresses a knowledge gap regarding the potential exacerbating effects of F-53B exposure on preexisting fatty liver disease and its underlying mechanisms.”
Sung, Y., Kim, H., Chae, Y., Yun, T., Kang, B.-T., & Kim, H. (2026) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2026.107017
HERNÁNDEZ-PÉREZ, S., Oidor-Chan, V. H., Rivera, J. P., Castrejón-Téllez, V., Oliart‐Ros, R. M., Carreón‐Torres, E., Ibarra-Lara, L., CHÁVEZ-REYES, Y., Castro-Rodríguez, D. C., Mendoza-García, P. G., et al. (2026) · Antioxidants · doi:10.3390/antiox15050592
Ashour, L., Alhawwari, A., Al-Nawaiseh, N. F., Basbous, S., Khawaldeh, T., Alomari, Z., Alzawahreh, Y., Zenha, K. A., Albweitel, T., Akileh, L., et al. (2026) · Precision Nutrition · doi:10.1097/pn9.0000000000000143
Fu, Y., Zeng, X., Zhou, B., Wang, J.-Y., & Qin, H. (2026) · Nutrients · doi:10.3390/nu18152431
“Under obese conditions, intramyocellular accumulation of lipotoxic metabolites impairs proximal insulin upstream of PI3K/AKT while simultaneously activating NF-kB-mediated transcription of pro-inflammatory cytokines such as TNF-alpha and IL-6 [39,40].”
Trisat, K., & Limpeanchob, N. (2026) · Journal of Applied Pharmaceutical Science · doi:10.1177/22313354261461030
“Elevated IL-6 levels are associated with impaired insulin responsiveness and alterations in key signaling components, including the insulin receptor and GLUT4 in hepatocytes 24,25 and adipocytes.”
Inzunza-Esparza, K., & García‐Escobar, A. (2026) · Life · doi:10.3390/life16091512
Andrès, E., Villalba, N. L., & Dali‐Youcef, N. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15187199
“Because sustained IL-6 signaling promotes hepatic insulin resistance and alters lipoprotein metabolism, IL-6 inhibition might be expected to improve some metabolic parameters, while paradoxically worsening lipid profiles [226,227].”
Cui, C., Zhao, Y., Zhang, G., Du, Z., & Cheng, W. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1928761
Syringin inhibits insulin resistance through the PI3K/AKT pathway
Wang, H., Han, J., Yun, L., & Wang, X. (2026) · Acta Pharmaceutica · doi:10.2478/acph-2026-0024
“…other factors affecting vital molecules in the insulin signalling pathway, such as increased expression of inflammatory factors like tumour necrosis factor alpha (TNF-α), due to obesity, endoplasmic reticulum stress (ERS), and oxidative stress, can inhibit the insulin signalling pathway (6).”
Gurba, M. O., & Салухов, В. В. (2026) · Russian Military Medical Academy Reports · doi:10.17816/rmmar706718
Mechanisms of epidermal growth factor receptor signalling in primary rat hepatocytes
Luo, Y. (2009) · DMU Open Research Archive (De Montfort University)
Young, J. L. (2008) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/4kma-sa11
“To specify which inflammatory player may be involved, in vitro experiments in primary murine hepatocytes and human HepG2 liver cell lines demonstrated that pretreatment with IL-6 led to a time-dependent decrease in IRS-1 tyrosine phosphorylation and Akt phosphorylation – key events in the insulin signaling pathway.(96…”
BackgroundImmunomodulation and metabolism: possible role of lactoferrin
Navarrete, M., & María, J. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Ahima, R. S., & Varela, G. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00332-6
The role of gp130 receptor signalling in inflammation and metabolism
Neill, B. (2010) · RMIT Research Repository (RMIT University Library) · doi:10.25439/rmt.27581208
Association of Maternal Adipokines with Infant Anthropometry in Obese, Pregnant Women
Gardner, A. (2011) · OhioLink ETD Center (Ohio Library and Information Network)
Metadata
- Authors
- Senn, J. J., Klover, P. J., Nowak, I. A., & Mooney, R. A.
- Affiliations
- University of Rochester Medicine (US)
- ORCID
- Mooney, Robert A.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2002-12-01
- Volume
- 51
- Issue
- 12
- Pages
- 3391-3399
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2130078845
- Cited by
- 883
- References
- 51
- Citations by year
- 2026: 27 · 2025: 19 · 2024: 22 · 2023: 29 · 2022: 28 · 2021: 41 · 2020: 42 · 2019: 31 · 2018: 31 · 2017: 36 · 2016: 49 · 2015: 46 · 2014: 46 · 2013: 34 · 2012: 39
- FWCI
- 23.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention (PHS R01 38138)
- U.S. Public Health Service
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- interleukin-6, insulin resistance, hepatocytes, insulin receptor signaling, IRS-1 tyrosine phosphorylation, phosphatidylinositol 3-kinase, p85 regulatory subunit, Akt activation, glycogen synthesis, type 2 diabetes, inflammatory cytokines
- MeSH terms
- Animals, Cell Line, Dose-Response Relationship, Drug, Humans, Insulin, Insulin Resistance, Phosphoproteins, Phosphorylation, Proto-Oncogene Proteins, Receptor, Insulin, Time Factors, Tyrosine, Signal Transduction, Interleukin-6, Protein Serine-Threonine Kinases, Phosphatidylinositol 3-Kinases, Hepatocytes, Proto-Oncogene Proteins c-akt, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
